there's absolutely covid stock fatigue: jefferies' michael yee
Published 2 years ago • 4K plays • Length 1:55
Download video MP4
Download video MP3
Similar videos
-
3:36
still a lot of uncertainty in moderna stock: jefferies' michael yee
-
2:36
the biggest wave of covid injections are behind us, says jefferies' michael yee
-
3:33
jefferies' michael yee still likes amgen in the biotech sector
-
2:46
biotech will face challenges this year, says jefferies' michael yee
-
3:19
melanoma vaccine data should make investors more positive on moderna, says jefferies' michael yee
-
4:22
covid is going to be a problem for the stocks of vaccine makers, says jefferies' michael yee
-
4:07
other market sectors will rally if we get a vaccine: jefferies' michael yee
-
5:00
jefferies michael yee explains why he is bullish on biotech in 2022
-
3:46
jefferies' michael yee on biogen as fda could be on the verge of approving alzheimer's drug
-
2:31
we still think there's more room for biotech to go higher, says jefferies' yee
-
2:57
jefferies' michael yee explains his top biotech picks: vrtx, fate, zlab
-
3:27
moderna stock down after positive booster news
-
4:31
jefferies' michael yee expects amgen's horizon therapeutics deal will go through despite ftc block
-
3:20
jefferies' michael yee expects big opportunities for a.i. in the biotech sector
-
3:52
biogen shares jump higher on report of potential samsung acquisition
-
3:34
pharma could see a wave of m&a activity in 2024, says jefferies' michael yee
-
5:58
we see big pharma going after smaller biotechs in 2024, says jefferies' michael yee
-
1:32
the pain isn't over yet for tech, says jefferies' thill
-
3:14
moderna's story is what's the encore to covid-19, says bank of america's geoff meacham
Clip.africa.com - Privacy-policy